Wednesday, June 24, 2020 9:40:51 PM
You're talking about IPIX having to notify AS that they feel they are not making "commercially reasonable efforts". Then within 20 days AS responds with some BS that proves they are making "commercially reasonable efforts".
I suspect getting them to relinquish their rights would require a protracted court battle. The licensing agreement definition of “Commercially Reasonable Efforts” is so subjective it would require a judgement and an appeal process to revoke those rights against AS's will.
Frankly it wouldn't be worth us getting a reputation as a difficult partner for an indication that probably is not worth anything if B-IBD works out.
http://myedgarpdf.com/datafeed2/?url=www.sec.gov/Archives/edgar/data/1355250/000147793219004223/0001477932-19-004223-index.htm
1.15 “Commercially Reasonable Efforts” means with respect to the efforts to be expended by any Party with respect to any objective, reasonable,
diligent, good faith efforts to accomplish such objective as such Party would use in its ordinary course of business to accomplish a similar objective under
similar circumstances. With respect to any objective relating to the Development and Commercialization of a Product by ALFASIGMA, “Commercially
Reasonable Efforts” means that level, caliber and quality of efforts and resources reasonably and normally used in the research, Development and
Commercialization by companies in the pharmaceutical industry of the size of ALFASIGMA for a compound or product which is of similar market potential and
at a similar stage in its Development or product life, taking into account, without limitation, with respect to the Product, issues of safety, efficacy, product
profile, competitiveness in the marketplace, including efforts used by similarly positioned competitors for competing products, regulatory structure involved,
timing for market entry, proprietary position, and other relevant scientific, technical, business, marketing, return on investment and other commercial factors.
Without limiting the generality of the foregoing, “Commercially Reasonable Efforts” requires that ALFASIGMA (a) promptly assigns responsibility for such
obligations to specific employees who are held accountable for progress and monitoring such progress on an ongoing basis, and (b) set and consistently seek
to adhere to the targets, budgeting and timelines (to the extent adherence to such activities and timelines are controllable by ALFASIGMA) set forth in the then
most current version of the Development Plan agreed upon by the Parties, unless ALFASIGMA has a reasonable basis to diverge from the Development Plan.
I'll leave it at that as I see the entire B-UP indication and deal as a side show distraction compared to COVID, OM, and IBD. If you're excited about B-UP and the prospects of reclaiming its development, more power to you.
Go IPIX!
Make IPIX Great Again!
Because now it looks like we were absolute geniuses for purchasing our antibiotic from bankruptcy court a year ago for $5 million." - LE
